This book presents the molecular basis, host–parasite interactions, and translational advances in malaria research, with a specific focus on Plasmodium falciparum. It examines parasite pathogenesis, including life cycle progression, erythrocyte invasion, cytoadherence, and immune evasion mechanisms that drive clinical disease. The book explores advances in parasite genomics and functional genomics, highlighting genome engineering approaches such as CRISPR-based editing for gene function analysis and drug target validation. It also covers contemporary malaria diagnostic strategies, including molecular and point-of-care platforms designed for sensitive detection and surveillance in low-transmission settings. In addition, the book discusses epitranscriptomic regulation and genetic determinants of antimalarial drug resistance, integrating molecular mechanisms with parasite adaptation under drug pressure. The final sections address antimalarial drug discovery, emphasizing natural products and modern target-based approaches for the development of new therapeutic agents.

Key Features:

1) Examines the molecular mechanisms underlying Plasmodium pathogenesis, host-parasite interactions, and cellular invasion processes

2) Explores CRISPR-based genome editing for target validation and functional genomics in malaria research.

3) Reviews the latest molecular diagnostics, biosensor platforms, and rapid point-of-care technologies.

4) Examines host immunity, immunopathology, and parasite-driven immune evasion mechanisms.

5) Discusses drug resistance mechanisms, gene-editing-based target identification, and novel therapeutic strategies.

This book is intended for researchers and students of molecular parasitology, immunology, and infectious diseases.